Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Insmed Inc. | 42 | 0 | 8 | 0 | €68.00 | €75.67 | 11.279% |
| Cytokinetics Inc. | 34 | 1 | 0 | 0 | €55.50 | €83.92 | 51.200% |
| Intra-Cellular Therapies Inc. | 31 | 0 | 1 | 0 | €75.00 | €83.92 | 11.894% |
| Trinity Biotech ADR | 27 | 0 | 3 | 0 | €0.41 | - | - |
| EyePoint Pharmaceuticals Inc. | 21 | 1 | 0 | 0 | €8.75 | €27.91 | 218.926% |
| Natural Alternat. | 21 | 1 | 3 | 0 | €5.15 | - | - |
| G1 Therapeutics | 21 | 1 | 0 | 0 | €3.64 | €10.54 | 189.813% |
| TG Therapeutics Inc. | 21 | 2 | 0 | 0 | €18.07 | €28.06 | 55.310% |
| Krystal Biotech | 17 | 0 | 0 | 0 | €196.30 | €186.59 | -4.947% |
| Geron Corp. | 17 | 0 | 1 | 0 | €4.29 | €5.56 | 29.627% |
| Esperion Therapeutis.Inc. | 17 | 1 | 1 | 0 | €2.23 | €8.55 | 282.691% |
| Rhythm Pharmaceuticals | 16 | 0 | 1 | 0 | €45.60 | €46.37 | 1.689% |
| Intellia Therapeutics Inc | 17 | 1 | 0 | 0 | €24.87 | €60.53 | 143.404% |
| Corcept Therapeutics Inc. | 15 | 0 | 1 | 0 | €32.80 | €36.87 | 12.402% |
| Rigel Pharmaceutical Inc. | 14 | 0 | 1 | 0 | €0.74 | €13.82 | 1767.203% |
| Catalyst Pharmaceutical Partners Inc | 13 | 0 | 0 | 0 | €16.20 | €24.44 | 50.882% |
| Verastem Inc. | 12 | 0 | 2 | 0 | €2.72 | €17.56 | 545.441% |
| MacroGenics Inc. | 12 | 0 | 0 | 0 | €5.10 | €12.42 | 143.622% |
| Prothena Corp. plc | 11 | 0 | 0 | 0 | €22.60 | €79.47 | 251.619% |
| Heron Therapeutics Inc. | 11 | 1 | 0 | 0 | €2.80 | €4.63 | 64.971% |
| WAVE Life Sciences Ltd | 9 | 0 | 0 | 0 | €5.80 | €14.05 | 142.172% |
| Chromadex Corp | 10 | 1 | 0 | 0 | €2.90 | €5.55 | 91.503% |
| Biocryst Pharmaceuticals | 9 | 0 | 0 | 0 | €7.24 | €11.05 | 52.670% |
| Adverum Biotechnologies Inc. | 9 | 0 | 1 | 0 | €1.38 | €20.55 | 1388.986% |
| BeiGene Ltd ADR | 9 | 1 | 0 | 0 | €151.00 | €241.54 | 59.963% |